Minghua Shan
Bayer (United States)
2 papers in the Anchorcite directory, published between 2007 and 2008, cited 18,093 times in total.
ORCID profileResearch topics
- Hepatocellular Carcinoma Treatment and Prognosis · 2 papers
- Renal cell carcinoma treatment · 2 papers
- Colorectal Cancer Treatments and Studies · 1 paper
- Bladder and Urothelial Cancer Treatments · 1 paper
Frequent co-authors
- Josep Maria Llovet · 1 paper
- Sergio Ricci · 1 paper
- Vincenzo Mazzaferro · 1 paper
- Philip a. Hilgard · 1 paper
- Edward John Gane · 1 paper
- Jean Frédéric Blanc · 1 paper
- André Cosme de Oliveira · 1 paper
- Armando Santoro · 1 paper
Papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 4,843 citations
BACKGROUND: We conducted a phase 3, randomized, double-blind, placebo-controlled trial of sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients with advanced clear-cell renal-cell carcinoma. METHODS: From November 2003 to March 2005, we randomly assigned 903 patients with…
Metadata from OpenAlex (CC0).